David Fielder
Family Medicine · Batesville, ARNPI 1821084377
Payments from drug & device makers
Across 114 payments — averaging $17.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$543
- Pfizer$215
- Abbott$192
- AstraZeneca$176
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$118
- Novo Nordisk$117
- plus $645 from 22 others
What the payments were for
- Food & beverage$2,006100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 32 | $543 |
| Pfizer | 13 | $215 |
| Abbott | 9 | $192 |
| AstraZeneca | 12 | $176 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $118 |
| Novo Nordisk | 7 | $117 |
| Medtronic | 1 | $81 |
| Johnson & Johnson | 4 | $69 |
| Astellas Pharma US Inc | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Novartis | 2 | $38 |
| Genentech USA, Inc. | 2 | $35 |
| Boehringer Ingelheim | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| AbbVie | 1 | $27 |
| Merck | 2 | $27 |
| GSK | 2 | $25 |
| Amarin Pharma, Inc. | 1 | $25 |
| Boston Scientific | 1 | $23 |
| Viatris Specialty LLC | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Mylan Specialty L.p. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$2,006 in reported general payments places this provider in the 70th percentile of 1,347 family medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 117 | $85,568 |
| OzempicSemaglutide | 45 | $53,910 |
| JanuviaSitagliptin Phosphate | 53 | $51,351 |
| JardianceEmpagliflozin | 54 | $45,314 |
| FarxigaDapagliflozin Propanediol | 44 | $33,208 |
| Risperdal ConstaRisperidone Microspheres | 13 | $32,129 |
| MounjaroTirzepatide | 30 | $31,211 |
| XareltoRivaroxaban | 18 | $15,665 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $14,147 |
| TradjentaLinagliptin | 17 | $13,891 |
| LinzessLinaclotide | 17 | $13,865 |
| TrulicityDulaglutide | 14 | $13,124 |
| MyrbetriqMirabegron | 26 | $12,671 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 22 | $11,133 |
| Repatha SureclickEvolocumab | 15 | $11,073 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $215 | $85,568117 claims |
| Boehringer IngelheimJardiance, Tradjenta | $32 | $59,20571 claims |
| Novo NordiskOzempic | $117 | $53,91045 claims |
| MerckJanuvia | $27 | $51,35153 claims |
| Johnson & JohnsonRisperdal Consta, Xarelto | $69 | $47,79431 claims |
| AstraZenecaFarxiga, Symbicort | $176 | $38,87864 claims |
| GSKAnoro Ellipta, Incruse Ellipta, Shingrix, Breo Ellipta | $25 | $30,34483 claims |
| AbbVieLinzess | $27 | $13,86517 claims |
| Astellas Pharma US IncMyrbetriq | $45 | $12,67126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Batesville
- George KonisLittle Rock$26.6M
- Kevin RobertsLittle Rock$2.5M
- Derek LewisLittle Rock$1.7M
- Jodi SansonHot Springs$1.7M
- Senthil RaghavanLittle Rock$496K
- Broderick EatonWynne$442K
- Landon HumphreyConway$417K
- Vonda HouchinHarrisburg$206K
- Glenn GibbonsFort Smith$179K
- Christopher BrownJonesboro$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.